TAIHO PHARMACEUTICAL CO., LTD.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Subsidiary
- Established
- 1963-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.taiho.co.jp
Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
Phase 3
Completed
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2007-07-09
- Last Posted Date
- 2012-11-02
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 834
- Registration Number
- NCT00498225
- Locations
- π¨π³
Chang Gung Memorial Hospital, Kaohsiung, No.123, Ta-Pei Rd., Niao-Sung Hsiang, Kaohsiung Hsien, Taiwan
π¨π³Chung-Ho Memorial Hospital, Kaohsiung Medical University, No.100, Tzyou 1st Rd., Kaohsiung, Taiwan
π―π΅National Cancer Center Hospital, Tokyo, Japan
Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy
Phase 3
Completed
- Conditions
- Chemotherapy-Induced Nausea and Vomiting
- Interventions
- First Posted Date
- 2006-08-02
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1140
- Registration Number
- NCT00359567
- Locations
- π―π΅
National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan
Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Phase 2
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Drug: CPT-11, 5-FU and l-LV
- First Posted Date
- 2006-01-31
- Last Posted Date
- 2012-11-02
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 426
- Registration Number
- NCT00284258
- Locations
- π―π΅
Saku Central Hospital, Saku City, Nagano, Japan
Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -
Phase 3
Completed
- Conditions
- Gastroesophageal Reflux
- Interventions
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 325
- Registration Number
- NCT00229424
- Locations
- π―π΅
Tohoku University Hospital, 1-1, Seiryo-cho, Aoba-ku, Sendai, Miyagi, Japan
Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Phase 3
Completed
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT00202969
- Locations
- π¨π³
Beijing Cancer Hospital, No.52 Fu-Cheng Road, Hai-dian District, Beijing, China
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)
Phase 3
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: Surgery alone
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 900
- Registration Number
- NCT00152230
- Locations
- π―π΅
National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Phase 3
Completed
- Conditions
- Gastric Cancer
- Interventions
- Drug: TS-1 (S-1)Procedure: Surgery
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1000
- Registration Number
- NCT00152217
- Locations
- π―π΅
National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan
A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)
Phase 3
Completed
- Conditions
- Breast Cancer
- Interventions
- Drug: cyclophosphamide, methotrexate, and fluorouracil
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1300
- Registration Number
- NCT00152191
- Locations
- π―π΅
National Cancer Center, 5-1-1, Tsukiji, chuo-ku, Tokyo, Japan
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)
Phase 3
Completed
- Conditions
- Gastric Cancer
- Interventions
- Procedure: Surgery alone
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 500
- Registration Number
- NCT00152243
- Locations
- π―π΅
Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6, Ariake, Koto-ku, Tokyo, Japan
The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)
Phase 3
Completed
- Conditions
- Breast Cancer
- Interventions
- Drug: CMF(cyclophosphamide, methotrexate, fluorouracil) and tamoxifen
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 680
- Registration Number
- NCT00152178
- Locations
- π―π΅
Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-1-3, Nakamichi, Higashinari-ku, Osaka, Osaka, Japan
Β© Copyright 2025. All Rights Reserved by MedPath